101 related articles for article (PubMed ID: 25196572)
1. Realgar nanoparticle-based microcapsules: preparation and in-vitro/in-vivo characterizations.
Shi F; Feng N; Omari-Siaw E
J Pharm Pharmacol; 2015 Jan; 67(1):35-42. PubMed ID: 25196572
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding.
Wu JZ; Ho PC
Eur J Pharm Sci; 2006 Sep; 29(1):35-44. PubMed ID: 16824739
[TBL] [Abstract][Full Text] [Related]
3. Enhanced antitumor activity of realgar mediated by milling it to nanosize.
Tian Y; Wang X; Xi R; Pan W; Jiang S; Li Z; Zhao Y; Gao G; Liu D
Int J Nanomedicine; 2014; 9():745-57. PubMed ID: 24516332
[TBL] [Abstract][Full Text] [Related]
4. Effect of size and processing method on the cytotoxicity of realgar nanoparticles in cancer cell lines.
Zhao W; Lu X; Yuan Y; Liu C; Yang B; Hong H; Wang G; Zeng F
Int J Nanomedicine; 2011; 6():1569-77. PubMed ID: 21845047
[TBL] [Abstract][Full Text] [Related]
5. [Study on the effect of realgar nanoparticles anti-adenovirus in vitro].
Cheng M; Wang CX; Wang HF; Gou BD; Zhu Z; Wang MZ; Xu HR; Xu WB
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Dec; 25(6):416-9. PubMed ID: 22734223
[TBL] [Abstract][Full Text] [Related]
6. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment.
Neupane YR; Srivastava M; Ahmad N; Kumar N; Bhatnagar A; Kohli K
Int J Pharm; 2014 Dec; 477(1-2):601-12. PubMed ID: 25445972
[TBL] [Abstract][Full Text] [Related]
7. [Differentiation of HL-60 cells induced by realgar nano-particles].
Luo LY; Zhang TL; Wang K
Zhongguo Zhong Yao Za Zhi; 2006 Aug; 31(16):1343-6. PubMed ID: 17061557
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of realgar nanoparticles and their inhibitory effect on rat glioma cells.
An YL; Nie F; Wang ZY; Zhang DS
Int J Nanomedicine; 2011; 6():3187-94. PubMed ID: 22238507
[TBL] [Abstract][Full Text] [Related]
9. Preparation, properties and anticancer effects of mixed As
Bujňáková Z; Baláž M; Zdurienčíková M; Sedlák J; Čaplovičová M; Čaplovič Ľ; Dutková E; Zorkovská A; Turianicová E; Baláž P; Shpotyuk O; Andrejko S
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():541-551. PubMed ID: 27987742
[TBL] [Abstract][Full Text] [Related]
10. Realgar (As4S4) nanoparticles and arsenic trioxide (As2O3) induced autophagy and apoptosis in human melanoma cells in vitro.
Pastorek M; Gronesova P; Cholujova D; Hunakova L; Bujnakova Z; Balaz P; Duraj J; Lee TC; Sedlak J
Neoplasma; 2014; 61(6):700-9. PubMed ID: 25150315
[TBL] [Abstract][Full Text] [Related]
11. [Study on the effect of realgar nanoparticles on reducing the respiratory syncytial virus type A (RSV-a) replication in vitro].
Cheng M; Zhao HL; Wang CX; Wang HF; Zhang Y; Gou BD; Zhu Z; Wang MZ; Xu WB
Bing Du Xue Bao; 2012 Jan; 28(1):45-50. PubMed ID: 22416349
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery.
Zhao QH; Zhang Y; Liu Y; Wang HL; Shen YY; Yang WJ; Wen LP
Med Oncol; 2010 Jun; 27(2):203-12. PubMed ID: 19280372
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of water-soluble polymer-encapsulated As4S4 to increase oral bioavailability and chemotherapeutic efficacy in AML mice.
Ma Q; Wang C; Li X; Guo H; Meng J; Liu J; Xu H
Sci Rep; 2016 Jul; 6():29348. PubMed ID: 27383126
[TBL] [Abstract][Full Text] [Related]
14. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia.
Fang W; Peng ZL; Dai YJ; Wang DL; Huang P; Huang HP
Drug Deliv; 2019 Dec; 26(1):1058-1067. PubMed ID: 31735064
[TBL] [Abstract][Full Text] [Related]
16. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
Das S; Ng WK; Kanaujia P; Kim S; Tan RB
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
[TBL] [Abstract][Full Text] [Related]
17. [The inhibitory effects of Realgar bioleaching solution on S180 ascites-tumor and its toxicity].
Xie QJ; Zhang X; Wang X; Bai L; Li HY
Zhong Yao Cai; 2009 Jun; 32(6):933-6. PubMed ID: 19764334
[TBL] [Abstract][Full Text] [Related]
18. [Apoptosis effects of drug sensitivity leukemia cells induced by nano-realgar].
Wang YS; Zhou ST; Wei HL
Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(13):2202-5. PubMed ID: 24079254
[TBL] [Abstract][Full Text] [Related]
19. [Realgar nano-particles induce apoptosis and necrosis in leukemia cell lines K562 and HL-60].
Ning N; Peng ZF; Yuan L; Gou BD; Zhang TL; Wang K
Zhongguo Zhong Yao Za Zhi; 2005 Jan; 30(2):136-40. PubMed ID: 15714820
[TBL] [Abstract][Full Text] [Related]
20. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y
Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
